diabetestalk.net

JDRF Celebrates Historic Artificial Pancreas Success Bringing Life-changing Benefits To People With Type 1 Diabetes

JDRF Celebrates Historic Artificial Pancreas Success Bringing Life-changing Benefits to People with Type 1 Diabetes

JDRF Celebrates Historic Artificial Pancreas Success Bringing Life-changing Benefits to People with Type 1 Diabetes

If your question was not addressed in the recording, please send it to [email protected]
FDA Approves Medtronic Hybrid Closed Loop System
On September 28, 2016, the type 1 diabetes (T1D) community reached a major breakthrough with the FDA's approval of the Medtronic hybrid closed loop system. The system is the first ever approved to automate the dosing of insulin to reduce high blood sugar levels.
The new Medtronic MiniMed 670G artificial pancreas system is a life-changing breakthrough that allows people with T1D to stay closer to their target blood sugar levels more consistently. JDRF celebrates a decade of dedicated partnership, collaboration, funding and advocacy that have made it possible to reach this landmark goal.
"Today's announcement is a historical achievement for JDRF and the entire T1D community. After years of laying the ground work, this life-changing breakthrough is a true testament to the reason JDRF exists, which is to accelerate ways to cure, prevent and treat this disease," said Derek Rapp, JDRF President and CEO.
The artificial pancreas system is designed to use Medtronic's MiniMed 670G insulin pump, 4th-generation sensors and a control algorithm to automate basal insulin delivery to maximize the time glucose levels are in a healthy range throughout the day and night. The system is fully integrated between the pump and sensor, with no need for a separate smartphone or CGM monitor. The AP system will give many people with T1D new freedom and peace of mind as for the first time, they may be able to sleep through the night without periodically waking up to che Continue reading

Rate this article
Total 1 ratings
Ginger reduces chronic inflammation, pain and migraines, helps digestion, diabetes and more

Ginger reduces chronic inflammation, pain and migraines, helps digestion, diabetes and more

(NaturalNews) According MedlinePlus, taking 1 gram of ginger before surgery may help reduce nausea and vomiting post-surgery. Widely known for its ability to reduce nausea and vomiting, ginger has many more uses than one may think. In China, ginger has been used for over 2,000 years to help treat nausea, stomach problems, arthritis and heart conditions.
This spicy herb also helps reduce chronic inflammation, pain and migraines. Ginger has been shown to help treat ulcers, gout and diabetes complications. It's a fantastic aid for those with digestive issues and has even been shown to beat several kinds of cancer cells. Gingerol and shogaol, two compounds found in ginger, are thought to be the active compounds responsible for ginger's many health benefits.
Ginger improves digestion
Ginger is a great post-meal treat that cleanses your palate and your sinuses. It's also an excellent aid to the digestive system. According to the Memorial Sloan-Kettering Cancer Center online, this spicy herb aids digestion by stimulating saliva and digestive juices. A 2008 study published in the European Journal of Gastroenterology and Hepatology showed that ginger helps the muscles of the stomach contract. This aids digestion by moving the contents of the stomach into the small intestine, a great help to sufferers of indigestion.
Ginger reduces inflammation
According to experts, inflammation of the colon is a precursor to colon cancer. A study published in the journal Cancer Prevention Research revealed that a ginger root supplement administered to participants reduced inflammation markers in the Continue reading

CRISPR Skin Grafts Could Replace Insulin Shots For Diabetes

CRISPR Skin Grafts Could Replace Insulin Shots For Diabetes

The potential of the gene editing tool CRISPR just seems to keep growing and growing, and the latest experimental use of the technology is creating skin grafts that trigger the release of insulin and help manage diabetes.
Researchers have successfully tested the idea with mice that gained less weight and showed a reversed resistance to insulin because of the grafts (high insulin resistance is a common precursor to type 2 diabetes).
In fact, the team from the University of Chicago says the same approach could eventually be used to treat a variety of metabolic and genetic conditions, not just diabetes – it's a question of using skin cells to trigger different chemical reactions in the body.
"We didn't cure diabetes, but it does provide a potential long-term and safe approach of using skin epidermal stem cells to help people with diabetes and obesity better maintain their glucose levels," says one of the researchers, Xiaoyang Wu.
If you're new to the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) phenomenon, it's a new and innovative way of editing specific genes in the body, using a biological copy and paste technique: it can do everything from cut out HIV virus DNA to slow the growth of cancer cells.
For this study, researchers used CRISPR to alter the gene responsible for encoding a hormone called glucagon-like peptide-1 (GLP-1), which triggers the release of insulin and then helps remove excess glucose from the blood.
Type 2 diabetes comes about due to a lack of insulin, also known as insulin resistance.
Using CRISPR, the GLP-1 gene could be tweaked t Continue reading

Turmeric Extract 100% Effective At Preventing Type 2 Diabetes, ADA Journal Study Finds

Turmeric Extract 100% Effective At Preventing Type 2 Diabetes, ADA Journal Study Finds

A remarkable human clinical study published in the journal Diabetes Care, the journal of the American Diabetes Association, revealed that turmeric extract was 100% successful at preventing prediabetic patients from becoming diabetic over the course of a 9-month intervention.[1]
Performed by Thailand researchers, the study's primary object was to assess the efficacy of curcumin, the primary polyphenol in turmeric which gives the spice its golden hue, in delaying the development of type 2 diabetes mellitus (T2DM) in a prediabetic population.
The study design was a randomized, double-blinded, placebo-controlled trial including 240 subjects who met the American Diabetic Association's criteria for prediabetes. All subjects were randomly assigned to receive either 250 mg of curcuminoid or placebo capsules for 9 months.
Type 2 diabetes progression was assessed by measuring a wide range of parameters, including changes in the insulin-producing cells within the pancreas known as β-cells, insulin resistance, and the anti-inflammatory cytokine known as adiponectin, at four different times: baseline, 3-, 6-, and 9-month visits during the course of intervention.
The results were reported as follows:
"After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level o Continue reading

I'm slim so why am I at risk of diabetes?

I'm slim so why am I at risk of diabetes?

Diabetes is on the rise around the world, and nowhere more rapidly than in developing countries that are adopting the sugary, starchy diet that has plagued the richer world for years. And it turns out that Asians, and especially South Asians, are particularly vulnerable.
The nutritionist runs a white measuring tape around my waist. I defy the urge to suck in my stomach.
I'm 42 years old, a mother of two and a journalist based in India's capital, Delhi, currently one of the world's most polluted cities. I eat organic food, rarely snack, and consider myself pretty slim and active, especially compared to my American friends, whom I can see on Facebook are generally twice my girth.
"It's 87cm (34.25in)," says Chaya Ranasinghe, nutritionist at Sri Lanka's National Diabetes Centre. I'm here to find out why slim-looking Indians and Sri Lankans are increasingly falling victim to type 2 diabetes - a disease we tend to associate with people who anyone could see were obese.
"Yes, but it should be 80cm (31.5in) maximum," she replies. "You are 7cm (2.75in) over."
"Should have sucked in my waist," I fume belatedly.
Chaya is helping me assess my risk for diabetes and the waist measurement is key for people of Asian origin. That's because Asian genes dictate that fat is laid down in the abdominal area.
It's this "visceral" or belly fat, as well as fat inside the liver, that puts us at risk.
"Imaging technology that measures fat in humans has shown that Asians of a healthy BMI have more fat around organs and in the belly area than Europeans with the same BMI, thereby increasing risk," accor Continue reading

No more pages to load

Popular Articles

Related Articles